FDA News
October 14, 2019
The FDA granted fast track designation to T-Guard for treatment of patients who develop steroid-refractory acute graft-versus-host disease after…
In the Journals
October 14, 2019
Medicare reimbursement policies that provide higher payments to hospitals than provider-based office settings for noninvasive cardiac tests lead to…
Meeting News
October 14, 2019
SAN DIEGO — Nephrology nurses are optimistic Advancing American Kidney Health will improve kidney care. However, getting to the goals set by…
In the Journals
October 14, 2019
Globally, the overall prevalence of hypertension in children and adolescents aged 19 years or younger is 4%, according to a systematic review and…
In the JournalsPerspective
October 14, 2019
Patients may experience better visual acuity if the duration of macular detachment is shortened to 3 days or less, according to a study conducted by…
In the Journals
October 14, 2019
Only 1 in 10 men and fewer than 2 in 10 women who did not receive osteoporosis therapy at the time of a fracture were prescribed adequate treatment…
FDA News
October 14, 2019
The FDA approved rivaroxaban for the prevention of venous thromboembolism among acutely ill hospitalized patients who are at risk for blood clots but…
October 14, 2019
California Governor Gavin Newsom signed legislation yesterday that will restrict the amount of money dialysis providers and drug rehabilitation…
In the Journals
October 14, 2019
Among Hispanic and Latino individuals in the United States, long sleep duration was associated with a decline in neurocognitive performance and…
Meeting News
October 14, 2019
SAN FRANCISCO — Robotic-assisted or fully robotic retinal surgery could improve patient outcomes by mitigating human limitations, according to…
Meeting NewsPerspective
October 14, 2019
CHICAGO — Among 51 patients with pseudarthrosis who underwent revision lumbar spine surgery and had intraoperative cultures, investigators…
Meeting News
October 14, 2019
CHICAGO — Among elderly patients with a spinal cord injury, researchers found the risk of morality was greater when patients had an increased…
Commentary
October 14, 2019
Diabetes affects 425 million people worldwide, and 1 in 2 adults remains undiagnosed, according to the International Diabetes Federation Diabetes…
October 14, 2019
As liver cancer rates continue to increase globally, researchers have focused on novel treatment options including combination therapies and…
Trial Scorecards
Cardiology Today, October 2019
Researchers evaluated the effect of twice-daily ticagrelor (Brilinta, AstraZeneca) on CV death, MI or stroke in patients with type 2 diabetes.
Trial Scorecards
Cardiology Today, October 2019
Evaluation of the efficacy, safety and tolerability of a subcutaneous injection of inclisiran (The Medicines Company).
Trial Scorecards
Cardiology Today, October 2019
Assessment of sacubitril/valsartan (Entresto, Novartis) vs. valsartan in patients with HF with preserved ejection fraction.
Trial Scorecards
Cardiology Today, October 2019
Assessment of safety and efficacy of ticagrelor (Brilinta, AstraZeneca) vs. prasugrel (Effient, Daiichi Sankyo/Eli Lilly) in patients with ACS for…
Trial Scorecards
Cardiology Today, October 2019
Researchers assessed bleeding risk of edoxaban (Savasya, Daiichi Sankyo) plus a P2Y12 inhibitor vs. a vitamin K antagonist, a P2Y12 inhibitor and…
Drug Risk Update
Cardiology Today, October 2019
Raymond L. Woosley, MD, PhD; C. Will Heise, MD; Jared Tate, PharmD; Tyler Gallo, PharmD; David Woosley, MPH; Klaus Romero, MS, MD
CredibleMeds, a valuable resource for prescribing physicians, now includes information from FDA drug labels to inform prescribers of any ECG…